Format

Send to

Choose Destination
Pediatrics. 2018 Dec;142(6). pii: e20181839. doi: 10.1542/peds.2018-1839. Epub 2018 Nov 7.

Neonatal Abstinence Syndrome Due to Maternal Kratom Use.

Author information

1
Mednax Incorporated, Sunrise, Florida whitney_eldridge@mednax.com.
2
Mednax Incorporated, Sunrise, Florida.

Abstract

Neonatal abstinence syndrome (NAS) is increasing in incidence and most commonly associated with maternal opioid use during pregnancy. Nonopioid alternatives to treat opioid dependence are highly sought after in the country's current opioid epidemic. Whether Kratom, a legal, widely available herbal supplement, should be classified as an opioid is contentious. Although the US Food and Drug Administration has recently addressed this controversy, Kratom continues to be marketed as a nonopioid remedy for opioid withdrawal. Its use is increasing in the United States. We describe an infant with NAS born to a mother with daily Kratom tea ingestion to self-treat opioid dependence. Pediatricians and parents should be aware of the risk of NAS due to Kratom use during pregnancy.

PMID:
30404789
DOI:
10.1542/peds.2018-1839

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center